Spots Global Cancer Trial Database for intercalation therapy using pemetrexed, cisplatin and erlotinib
Every month we try and update this database with for intercalation therapy using pemetrexed, cisplatin and erlotinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation | NCT02795884 | NSCLC | intercalation t... Vinorelbine, ci... | 19 Years - | Yonsei University | |
Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation | NCT02795884 | NSCLC | intercalation t... Vinorelbine, ci... | 19 Years - | Yonsei University |